Este artigo apresenta o consenso realizado pelo Departamento Científico de Neurologia
Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia sobre os critérios …

Atualmente não há tratamento curativo para as demências neurodegenerativas ou para a
demência vascular, mas algumas intervenções farmacológicas e não farmacológicas podem …

Across Latin American and Caribbean countries (LACs), the fight against dementia faces
pressing challenges, such as heterogeneity, diversity, political instability, and socioeconomic …

Esse texto apresenta as recomendações da Academia Brasileira de Neurologia (ABN), por
intermédio do seu Departamento Científico de Neurologia Cognitiva e do Envelhecimento (…

Naming difficulty is common in Alzheimer's disease (AD), but the nature of this problem is
not well established. The authors investigated the presence of semantic breakdown and the …

A demência da doença de Parkinson (DDP) e a demência com corpos de Lewy (DCL)
representam a segunda causa mais comum de demência neurodegenerativa em pessoas com …

The search for an Alzheimer's disease (AD) biomarker is one of the most relevant contemporary
research topics due to the high prevalence and social costs of the disease. Functional …

Previous studies demonstrated cognitive impairments in spinocerebellar ataxia type 3 (SCA3/MJD);
however, there is no consensus about the cognitive domains affected and the …

There is evidence that the default mode network (DMN) functional connectivity is impaired in
Alzheimer's disease (AD) and few studies also reported a decrease in DMN intrinsic activity, …

ADAM10 is the main α-secretase that participates in the non-amyloidogenic cleavage of
amyloid precursor protein (APP) in neurons, inhibiting the production of β-amyloid peptide (Aβ) …